A Single Center Phase II Assessor -Blinded RaNdomised Active Controlled Parallel-Group Trial to COmpare Ticagrelor Versus Clopidogrel on the REduction of ArteriaL STiffness and Wave Reflections in Patients With CoronarY Artery Disease. The NOVELTY Study
Phase of Trial: Phase II
Latest Information Update: 07 Mar 2017
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease
- Focus Pharmacodynamics
- Acronyms NOVELTY
- 01 Mar 2017 Planned End Date changed from 1 Dec 2015 to 1 Jun 2017.
- 01 Mar 2017 Planned primary completion date changed from 1 Dec 2015 to 1 Jun 2017.
- 15 Apr 2015 Planned End Date changed from 1 Feb 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov